Citation: Bh. King et al., Case series: Amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities, J AM A CHIL, 40(6), 2001, pp. 654-657
Authors:
King, BH
Wright, DM
Handen, BL
Sikich, I
Zimmerman, AW
McMahon, W
Cantwell, E
Davanzo, PA
Dourish, CT
Dykens, EM
Hooper, SR
Jaselskis, CA
Leventhal, BL
Levitt, J
Lord, C
Lubetsky, MJ
Myers, SM
Ozonoff, S
Shah, BG
Snape, M
Shernoff, EW
Williamson, K
Cook, EH
Citation: Bh. King et al., Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder, J AM A CHIL, 40(6), 2001, pp. 658-665
Citation: Sp. Vickers et al., Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors, NEUROPHARM, 41(2), 2001, pp. 200-209
Citation: Pg. Clifton et al., Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat, PSYCHOPHAR, 152(3), 2000, pp. 256-267
Citation: Sp. Vickers et al., Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity inrats, BR J PHARM, 130(6), 2000, pp. 1305-1314
Authors:
Weiss, SM
Wadsworth, G
Fletcher, A
Dourish, CT
Citation: Sm. Weiss et al., Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety, NEUROSCI B, 23(2), 1998, pp. 265-271